METALLOTHIONEINS IN BRAIN - THE ROLE IN PHYSIOLOGY AND PATHOLOGY

Citation
M. Aschner et al., METALLOTHIONEINS IN BRAIN - THE ROLE IN PHYSIOLOGY AND PATHOLOGY, Toxicology and applied pharmacology, 142(2), 1997, pp. 229-242
Citations number
119
Categorie Soggetti
Pharmacology & Pharmacy",Toxicology
ISSN journal
0041008X
Volume
142
Issue
2
Year of publication
1997
Pages
229 - 242
Database
ISI
SICI code
0041-008X(1997)142:2<229:MIB-TR>2.0.ZU;2-6
Abstract
A symposium on the role of brain metallothioneins (MTs) in physiology and pathology was held at the 1996 Annual Society of Toxicology Meetin g in Anaheim, California. The objectives of this symposium were to: (1 ) review the physiologic function of MTs, (2) examine the distribution of brain MTs with particular emphasis on cell-specific localization ( neurons vs neuroglia), (3) discuss MT gene responsiveness upon toxic i nsult with metals, and (4) discuss the potential role of MTs in the et iology of neurodegenerative disorders. Dr. Cherian discussed the bioch emical properties of the MTs, emphasizing structural similarities and differences between the MTs. Dr. Klaassen addressed the expression and distribution of the MTs in brains with special reference to the cell- specific localization of MTs. Dr. Aschner provided data illustrating a potential role for MTs in attenuating the cytotoxicity caused by meth ylmercury (MeHg) in cultured neonatal astrocytes. Dr. Palmiter discuss ed the properties of MT-III and the increased sensitivity of MT-III kn ockout mice to kainate-induced seizures. Cerebral zinc metabolism its relationship to MT homeostasis, and its pathogenic potential in Alzhei mer's disease was addressed by Dr. Bush. (C) 1997 Academic Press.